Homology modeling and QSAR analysis of 1,3,4-thiadiazole and 1,3,4-triazole derivatives as carbonic anhydrase inhibitors

Indian Journal of Biochemistry and Biophysics

Volumn 47, Issue 4, 2010, Pages 234-242

  Akula, N V Murali Krishna ^a   Kumar, Surendra ^a   Singh, Vineet ^a   Tiwari, Meena ^a  

^a SHRI G S INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Anti tumor; Carbonic anhydrase inhibitor; Homology; Modeller 9v2; QSAR

Indexed keywords

1,3,4 THIADIAZOLE; 1,3,4-THIADIAZOLE; CARBONATE DEHYDRATASE INHIBITOR; ISOPROTEIN; THIADIAZOLE DERIVATIVE; TRIAZOLE DERIVATIVE;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL MODEL; CHEMISTRY; CRYSTALLIZATION; DOSE RESPONSE; DRUG SCREENING; ELECTRON; HUMAN; IC 50; MOLECULAR GENETICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL;

AMINO ACID SEQUENCE; CARBONIC ANHYDRASE INHIBITORS; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTRONS; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, CHEMICAL; MODELS, STATISTICAL; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; THIADIAZOLES; TRIAZOLES;

MURINAE;

EID: 77956123230     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Sly W S & Hu P Y (1995) Annu Rev Biochem 64, 375-401
2. Scozzafava A, Mastrolorenzo A & Supuran C T (2006) Expert Opin Ther Pat 16, 1627-1664
3. Hilvo M, Tolvanen M, Clark A, Shen B, Shah G N, Waheed A, Halmi P, Hanninen M, Hamalainen J M, Vihinen M, Sly W S & Parkkila S (2005) Biochem J 392, 83-92
4. Svastova E, Hulikova A, Rafajova M, Zatovicova M, Gibadulinova A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J & Pastorekova S (2004) FEBS Lett 577, 439-445
5. Supuran C T (2003) Expert Opin Invest Drugs 12, 283-287
6. Supuran C T, Scozzafava A & Casini A (2003) Med Res Rev 23, 146-189
7. Scozzafava A, Owa T, Mastrolorenzo A & Supuran C T (2003) Curr Med Chem 10, 925-953
8. Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, Pastorekova S & Supuran C T (2003) J Enz Inhib Med Chem 18, 403-406
9. Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, Pastorekova S & Supuran C T (2003) Bioorg Med Chem Lett 13, 1005-1009
10. Winum J Y, Vullo D, Casini A, Montero J L, Scozzafava A & Supuran C T (2003) J Med Chem 46, 5471-5477
11. Winum J Y, Vullo D, Casini A, Montero J L, Scozzafava A & Supuran C T (2003) J Med Chem 46, 2197-2204
12. Potter C & Harris A L (2004) Cell Cycle 3, 164-167
13. Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J & Supuran C T (2004) Bioorg Med Chem Lett 14, 869-873
14. Rafajova M, Zatovicova M, Kettmann R, Pastorek J & Pastorekova S (2004) Int J Oncol 24, 995-1004
15. Robertson N, Potter C & Harris A L (2004) Cancer Res 64, 6160-6165
16. Pastorekova S, Parkkila S, Pastorek J & Supuran C T (2004) J Enz Inhib Med Chem 19, 199-229
17. Casini A, Antel J, Abbate F, Scozzafava A, David S, Waldeck H, Schafer S & Supuran C T (2003) Bioorg Med Chem Lett 13, 841-845
18. Abbate F, Casini A, Scozzafava A & Supuran C T (2003) J Enz Inhib Med Chem 18, 303-308
19. Casini A, Abbate F, Scozzafava A & Supuran C T (2003) Bioorg Med Chem Lett 13, 2759-2763
20. Abbate F, Casini A, Scozzafava A & Supuran C T (2004) Bioorg Med Chem Lett 14, 2357-2361
21. Abbate F, Coetzee A, Casini A, Ciattini S, Scozzafava A & Supuran C T (2004) Bioorg Med Chem Lett 14, 337-341
22. Abbate F, Winum J Y, Potter B V, Casini A, Montero J L, Scozzafava A & Supuran C T (2004) Bioorg Med Chem Lett 14, 231-234
23. Abbate F, Casini A, Owa T, Scozzafava A & Supuran C T (2004) Bioorg Med Chem Lett 14, 217-223
24. Almajan G A, Innocenti A, puccetti L, Manole G, Stefania B, Ioana S, scozzafova A & Supuran C T (2005) Bioorg Med Chem Lett 15, 2347-2352
25. Anne T, Marie L, Cecchi A, Dogne J M, Wouters J, Supuran C T & Masereel B (2006) J Med Chem 49, 2743-2749
26. Tuccinardi T, Ortore G, Rosello A, Supuran C T & Martinelli A (2007) J Chem Inf Model 47, 2253-2262
27. Eswar N, Marti-Renom M A, Webb B, Madhusudhan M S, Eramian D, Shen M, Pieper U & Sali A (2006) Current Protocols in Bioinformatics, Suppl 15, 5.6.1-5.6.30, John Wiley and Sons, Inc.
28. Altschul S F, Madden T L, Schaffer A A, Zhang J, Zhang Z, Miller W & Lipman D J (1997) Nucleic Acids Res 25, 3389-3402
29. Ren J H, Xiong X Q, Sha Y, Yan M C, Lin B, Wang J, Jing J K, Zhao D M & Cheng M S (2008) Mol Simul 34, 337-346
30. Whittington D A, Grubb J H, Waheed A, Shah G N, Sly W S & Christianson D W (2004) J Biol Chem 279, 7223-7228
31. Ramachandran G N & Sasisekharan V (1968) Adv Protein Chem 23, 283-438
32. Fischer J, Hrernandez P J, Duda D, Yoshika H, Govindaswamy L, Silverman D N & Mckenna R (2005) Biochemistry 44, 1097-1105
33. Molcular Operating Environment 2006. 08), Chemical Computing Group Inc. 1010 Sherbrooke st. W, Suite 910, Montreal, Quebec, Canada
34. Gupta A K, Arockia B M & Kaskhedikar S G (2004) Indian J Pharm Sci 66, 396-402
35. Roy P P, Paul S, Mitra I & Roy K (2009) Molecules 14, 1660-1701
36. Misawa T, Aoyama H, Furuyama T, Dodo K, Sagawa M, Miyachi H, Kizaki M & Hasimoto Y (2008) Chem Pharm Bull 56, 1490-1495
37. http://www.chemcomp.com/journal/descr.htm
38. Om Praba G & Velmurugan D (2007) Indian J Biochem Biophys 47, 470-476
39. Labute PA (2000) J Mol Graph Model 18, 464-77
40. Baurin N, Mozziconzcci J C, Arnoult E, Chavette P, Marot C & Morin-Allory L (2004) J Chem Inf Comput Sci 44, 276
41. Hanumantharao P, Sambasivarao S V, Soni L K, Gupta A K & Kaskhedikar S G (2005) Bioorg Med Chem Lett 15, 3167-3173
42. Dubus F, Ijjali I, Petitet F & Michel A (2006) Chem Med Chem 1, 622-630